10:28 AM EDT, 05/24/2024 (MT Newswires) -- (Updates to add details in the second, third and fourth paragraph.)

Eli Lilly ( LLY ) said Friday it is investing an additional $5.3 billion into its manufacturing site in Lebanon, Indiana, bringing its total investment to $9 billion.

This investment will boost the production of active pharmaceutical ingredients for weight-loss drug Zepbound and type 2 diabetes medicine Mounjaro, the drugmaker said.

Eli Lilly ( LLY ) said it expects to add 200 full-time jobs, including engineers and lab technicians, resulting in an estimated 900 full-time workers when the site is fully operational. There will also be more than 5,000 construction jobs during the site's development.

The facility is expected to start drug production by the end of 2026 and expand operations through 2028, the company said.

Price: 808.79, Change: +0.34, Percent Change: +0.04